Canada markets closed
  • S&P/TSX

    20,383.75
    +97.55 (+0.48%)
     
  • S&P 500

    3,978.73
    +37.25 (+0.95%)
     
  • DOW

    32,120.28
    +191.66 (+0.60%)
     
  • CAD/USD

    0.7806
    +0.0006 (+0.07%)
     
  • CRUDE OIL

    110.87
    +0.54 (+0.49%)
     
  • BTC-CAD

    38,163.59
    +57.15 (+0.15%)
     
  • CMC Crypto 200

    659.93
    -11.08 (-1.65%)
     
  • GOLD FUTURES

    1,852.00
    +5.70 (+0.31%)
     
  • RUSSELL 2000

    1,799.16
    +34.34 (+1.95%)
     
  • 10-Yr Bond

    2.7490
    -0.0110 (-0.40%)
     
  • NASDAQ futures

    11,913.75
    -28.50 (-0.24%)
     
  • VOLATILITY

    28.37
    -1.08 (-3.67%)
     
  • FTSE

    7,522.75
    +38.40 (+0.51%)
     
  • NIKKEI 225

    26,677.80
    -70.34 (-0.26%)
     
  • CAD/EUR

    0.7297
    +0.0033 (+0.45%)
     

Why Nanox Stock Lost Almost 30% in December

·3 min read
Why Nanox Stock Lost Almost 30% in December
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Nano-X Imaging (NASDAQ: NNOX), commonly referred to as Nanox, fell 29.5% in December, according to data provided by S&P Global Market Intelligence. The company did get Food and Drug Administration (FDA) clearance in December, but not the one investors were hoping for, which might explain the stock's underperformance for the month. Nanox plans to commercialize a medical device called the multi-source Nanox.ARC, which can quickly and cheaply make a digital X-ray.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting